- Home
- BNC vs NCNA Comparison
BNC vs NCNA Comparison
Compare BNC & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNC
- NCNA
- Stock Information
- Founded
- BNC N/A
- NCNA 1997
- Country
- BNC United States
- NCNA United Kingdom
- Employees
- BNC N/A
- NCNA N/A
- Industry
- BNC Industrial Machinery/Components
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- BNC Industrials
- NCNA Health Care
- Exchange
- BNC Nasdaq
- NCNA Nasdaq
- Market Cap
- BNC 13.7M
- NCNA 15.4M
- IPO Year
- BNC N/A
- NCNA 2017
- Fundamental
- Price
- BNC $27.34
- NCNA $4.47
- Analyst Decision
- BNC
- NCNA Buy
- Analyst Count
- BNC 0
- NCNA 2
- Target Price
- BNC N/A
- NCNA $25.00
- AVG Volume (30 Days)
- BNC 1.0M
- NCNA 187.0M
- Earning Date
- BNC 08-22-2025
- NCNA 08-18-2025
- Dividend Yield
- BNC N/A
- NCNA N/A
- EPS Growth
- BNC N/A
- NCNA N/A
- EPS
- BNC N/A
- NCNA N/A
- Revenue
- BNC $3,478,254.00
- NCNA N/A
- Revenue This Year
- BNC N/A
- NCNA N/A
- Revenue Next Year
- BNC N/A
- NCNA N/A
- P/E Ratio
- BNC N/A
- NCNA N/A
- Revenue Growth
- BNC 10.08
- NCNA N/A
- 52 Week Low
- BNC $5.60
- NCNA $0.03
- 52 Week High
- BNC $82.88
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- BNC N/A
- NCNA 30.91
- Support Level
- BNC N/A
- NCNA $7.06
- Resistance Level
- BNC N/A
- NCNA $10.00
- Average True Range (ATR)
- BNC 0.00
- NCNA 1.44
- MACD
- BNC 0.00
- NCNA 0.07
- Stochastic Oscillator
- BNC 0.00
- NCNA 3.94
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.